Reciprocal relationship from GYRE graph: associated with chronic liver disease (“CLD”) and chronic idiopathic thrombocytopenia (“ITP”). Other Product Candidates F573 is our clinical-stage product can…
roduct sales to date, although we have historically generated revenue from our licensing agreement with Samil Pharm. Co., Ltd., or Samil. We have incurred operating losses in each year since the ince…
Reciprocal relationship from MTVA graph: ing. Accordingly, shares registered under such registration statements will be available for sale in the open market. In the future, we may also issue our sec…
Reciprocal relationship from VKTX graph: Reciprocal relationship from GLMD graph: Reciprocal relationship from VKTX graph: Reciprocal relationship from GLMD graph: Reciprocal relationship from VKTX g…
Galmed Pharmaceuticals Ltd. Debt Obligations
Instrument
Description
Confidence
Evidence
GLMD-DEBT-9800
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2015-12-31.
Galmed Pharmaceuticals Ltd. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Galmed Pharmaceuticals Ltd..
Galmed Pharmaceuticals Ltd. Ownership
Holder
Name
Confidence
Evidence
GLMD-OWNER-TWO-SIGMA-INVESTMENTS-LP
Two Sigma Investments, LP
95%
13F/ownership overlay lists Two Sigma Investments, LP; shares held 112,147; ownership 1.70%; value $69,800; as of 2025-12-31.
GLMD-OWNER-CITADEL-ADVISORS-LLC
Citadel Advisors Llc
95%
13F/ownership overlay lists Citadel Advisors Llc; shares held 38,177; ownership 0.58%; value $23,761; as of 2025-12-31.
GLMD-OWNER-XTX-TOPCO-LTD
Xtx Topco Ltd
95%
13F/ownership overlay lists Xtx Topco Ltd; shares held 11,048; ownership 0.17%; value $6,876; as of 2025-12-31.
GLMD-OWNER-UBS-GROUP-AG
UBS Group AG
95%
13F/ownership overlay lists UBS Group AG; shares held 1,814; ownership 0.03%; value $1,129; as of 2025-12-31.
GLMD-OWNER-BNP-PARIBAS-FINANCIAL-MARKETS
BNP Paribas Financial Markets
95%
13F/ownership overlay lists BNP Paribas Financial Markets; shares held 900; ownership 0.01%; value $560; as of 2025-12-31.
GLMD-OWNER-MORGAN-STANLEY
Morgan Stanley
95%
13F/ownership overlay lists Morgan Stanley; shares held 298; value $185; as of 2025-12-31.
GLMD-OWNER-TSFG-LLC
Tsfg, Llc
95%
13F/ownership overlay lists Tsfg, Llc; shares held 17; value $10; as of 2025-12-31.
GLMD-OWNER-JANE-STREET-GROUP-LLC
Jane Street Group, LLC
95%
13F/ownership overlay lists Jane Street Group, LLC; shares held 12,135; ownership 0.18%; value $7,552; as of 2025-12-31.
